Capricor Therapeutics, Inc.
CAPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $454 | $433 | $486 |
| - Cash | $20 | $23 | $29 | $11 |
| + Debt | $14 | $1 | $1 | $1 |
| Enterprise Value | – | $432 | $406 | $476 |
| Revenue | $0 | $0 | $0 | $11 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$20 | -$22 | -$19 | -$3 |
| % Margin | – | – | – | -30.8% |
| EBITDA | -$24 | -$27 | -$25 | -$7 |
| % Margin | – | – | – | -65.8% |
| Net Income | -$25 | -$26 | -$24 | -$7 |
| % Margin | – | – | – | -63.9% |
| EPS Diluted | -0.54 | -0.57 | -0.53 | -0.16 |
| % Growth | 5.3% | -7.5% | -231.3% | – |
| Operating Cash Flow | $0 | -$20 | -$6 | -$15 |
| Capital Expenditures | $0 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | -$22 | -$8 | -$16 |